ライフサイエンスコーパス: were comparable

1 Median times to neutrophil and platelet engraftment were comparable.

2 Quantitative results from both methods were comparable.

3 The performances of the ML and LR models were comparable.

4 animals and tools would remain, when image gist statistics were comparable across categories.

5 tion cohort 1, and 0.711 for the validation cohort 2, which were comparable among each other.

6 umber of patients, age, gender, surgeon, and osteotomy size were comparable among groups (p = 0.4-0.9).

7 tion-to-screen analysis, advanced neoplasia detection rates were comparable among the control (1.1%), sequential (1.0%),

8 re discovered in 27.6% of pCND patients, oncologic outcomes were comparable at 1 year.

9 h, EQ5D-3L, Visual Analog Scale, and Functional Pain scores were comparable between groups over time.

10 s of explantation, infection, tissue necrosis, and hematoma were comparable between groups.

11 The incidences of adverse events were comparable between S/V and enalapril across all 4 subgro

12 PAD severity and medical treatment were comparable between sexes, whereas prior lower extremity

13 TFV-DP concentrations at week 4 were comparable between TGW and TGM (mean difference -6%; 95%

14 Although all the mucoinflammatory features were comparable between the immunocompetent Tg(+) and Rag1 (K

15 0%, 89.5%, 78.2%; non-CACPR: 96.9.9%, 88.7%, 80.0%; P = .4) were comparable between the two groups.

16 ve microorganisms, comorbidities, and durations of symptoms were comparable between time intervals.

17 Periodontal parameters were comparable but the proportion of patients with high PIRI

18 Even the expression of Kv4.3 channels were comparable, despite evidences showing that Kv4.3-mediate

19 on devices, procedural, postprocedural, and 1-year outcomes were comparable following TAVR for bicuspid AV versus tricusp

20 Rates of new-onset HF between January 1 and March 11 were comparable for 2020 and 2019 (1.83 versus 1.78 per 10 00

21 Histopathologic features following radiation were comparable in all patients and were characterized by are

22 Both groups were comparable in baseline characteristics, including age, p

23 tes of the individual components of the composite endpoints were comparable in both groups.

24 les also elicited IgM, IgG1, IgG2b, and IgG3 responses that were comparable in magnitudes to wild-type mice, suggesting t

25 Findings were comparable in prespecified subanalyses of children born

26 While epoxide and diol levels were comparable in tumors from both genotypes, prostaglandin

27 ~77% higher in NN plots than LN and HN plots in SG but they were comparable in unfertilized and fertilized plots in GG.

28 The results obtained with developed MFC biosensor were comparable to conventional methods such as colorimetric,

29 ent accumulation factors (L-PFOS BSAF(Perch liver): 22-559) were comparable to elsewhere, and concentrations of PFAA prec

30 n general, the estimates of reliability for problem-solving were comparable to estimates from the literature for other an

31 Phototransformation rates were comparable to or as much as 60% slower than those predic

32 le gas emission rates from components on gathering stations were comparable to or higher than emission factors utilized b

33 l swab samples of individuals with suspected COVID-19 cases were comparable to paired results from a CDC-approved quantit

34 idence of relapse of patients with a KIR-advantageous donor were comparable to patients with a KIR-disadvantageous donor.

35 patient cell lines displayed DNA damage repair defects that were comparable to previously observed RNAi-mediated depletio

36 Results from the IPP pouch were comparable to standard quantitative polymerase chain rea

37 engths of chromosomes harboring the integrated virus genome were comparable to the other chromosomes.

38 biomarker-based clusters, 3 of which (clusters B, C, and D) were comparable to the previously identified clusters.

39 vival rates of mechanically-sorted larvae were over 90% and were comparable to those achieved by careful hand-sorting.

40 ulations found that effective doses for [(55)Co]Co-DOTATATE were comparable to those for both [(64)Cu]Cu-DOTATATE and [(6

41 ificity of the eazyplex PJA (95.7% and 96.5%, respectively) were comparable to those for three different P. jirovecii qPC

42 Reported adverse events were comparable to those noted in previously reported profile

43 (both inner and outer) as well as frequency maps of the BM were comparable to those obtained by other methods, but with

44 The cycle threshold (Ct) values of our multiplex RT-qPCR were comparable to those obtained by the single assay adapted

45 imated effective human doses for adult male and female mice were comparable to those of other (18)F-based imaging probes.

46 in asthma, and its amplitude, percent rhythm, and acrophase were comparable to those of peak expiratory flow or serum cor

47 ght (0.61 vs 0.82; P = .453) from randomization to month 36 were comparable, whereas growth in prepubertal patients on EV

48 ed traits in adolescents, although still relatively modest, were comparable with or slightly smaller than in adults offer

49 c histomorphometric analyses e.g., mineral apposition rates were comparable with similar data from preclinical rodent mod

50 capacities and overall likeness score of DP or DJ infusion were comparable with the commercial FF infusion.